


Alera Bio Revenue
Biotechnology Research • Chicago, Illinois, United States • 1-10 Employees
Alera Bio revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Alera Bio
Frank Jaeger
Founder
Company overview
| Headquarters | Chicago, Illinois, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About Alera Bio
Alera Bio is a next-generation biotechnology company focused on delivering transformative therapies for rare and neglected neurological disorders. By uniting scientific innovation with a deep sense of urgency, Alera Bio is accelerating solutions for patients and families who have long been overlooked. Grounded in translational research and strategic development, the company is built to drive meaningful impact where it matters most—at the intersection of biology, unmet medical need, and real-world patient outcomes. Headquartered in Chicago, IL, Alera Bio is actively identifying and evaluating therapeutic opportunities aligned with orphan drug and 505(b)(2) regulatory pathways. With a capital-efficient model and deep domain expertise, the company is positioned to rapidly advance development-ready assets that address urgent gaps in care for underserved neurological conditions.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Alera Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Alera Bio has never raised funding before.
Frequently asked questions
4.8
40,000 users



